Compare PAGP & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAGP | CAI |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Natural Gas Distribution | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 2013 | N/A |
| Metric | PAGP | CAI |
|---|---|---|
| Price | $26.03 | $15.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | $22.11 | ★ $30.91 |
| AVG Volume (30 Days) | 1.8M | ★ 2.8M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.90% | N/A |
| EPS Growth | ★ 370.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $44,262,000,000.00 | N/A |
| Revenue This Year | $10.57 | $25.24 |
| Revenue Next Year | N/A | $22.32 |
| P/E Ratio | $94.44 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.69 | $14.19 |
| 52 Week High | $25.79 | $42.50 |
| Indicator | PAGP | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 72.40 | 40.86 |
| Support Level | $22.77 | $14.19 |
| Resistance Level | N/A | $19.79 |
| Average True Range (ATR) | 0.60 | 1.09 |
| MACD | 0.22 | -0.10 |
| Stochastic Oscillator | 95.17 | 23.80 |
Plains GP Holdings LP owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), and natural gas. The group manages its operations through two operating segments: Crude Oil segment operations generally consist of gathering and transporting crude oil using pipelines (including gathering systems), trucks, and, at times, on barges or railcars; and NGL segment operations involve NGL storage and terminalling from NGL assets located in the Southwestern United States. It generates the majority of its revenue from the Crude Oil segment. Its geographic markets are the United States and Canada. It generates the majority of its revenue from the United States.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.